Belgium

Belgium – Covid-19 coronavirus: ban on at-home tests lifted

Tine Carmeliet

On 21 September 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced that, as of 19 September 2020, the ban on the sale of Covid-19 at-home tests, which has been in place since March 2020, has been lifted. The at-home tests aim to detect antibodies against coronavirus SARS-CoV-2 without the intervention of a Read More

Belgium: Covid-19 coronavirus: measures to combat medicine shortages extended again

Veerle Pissierssens

Since April 2020, the Belgian government has taken measures to avoid medicine shortages during the Covid-19 pandemic. These measures have subsequently been revised and extended in duration four times. The measures have now been further extended until 28 October 2020 by a Federal Agency for Medicines and Health Products (FAMHP) decision dated 25 September 2020, Read More

Belgium: Covid-19: FAMHP adopts new validation procedure for serological tests

Tine Carmeliet

On 30 April 2020, the Federal Agency for Medicines and Health Products (FAMHP) established a verification procedure for Covid-19 tests (see our previous blog post Covid-19: measures affecting the life sciences sector (Belgium)). On 6 September 2020, FAMHP announced  that it will gradually return to the conventional way of working (that is, the method being Read More

Belgium – Covid-19 coronavirus: using saliva samples to detect SARS-CoV-2 as an alternative to sampling via a deep nasal swab?

Veerle Pissierssens

The Belgian federal taskforce on testing and shortages commissioned a study that was launched on 28 May 2020 on the use of saliva samples as an alternative to sampling via a deep nasal swab (nasopharyngeal) to detect SARS-CoV-2 using PCR molecular detection tests. The purpose of the study, supported by Sciensano, a public research institution, Read More

Belgium – FAMHP supports e-PIL pilot project

Tine Carmeliet

On 17 August 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced its support for the pilot project on electronic patient information leaflets, e-PIL, a project replacing the traditional paper package leaflet for certain medicines with electronic leaflets on trusted websites, which was initiated by the Belgian and Luxembourgian pharmaceutical industry in 2018. Read More